Wikidata

(Q34012525)

English

FDA drug approval summary: nelarabine (Arranon) for the treatment of T-cell lymphoblastic leukemia/lymphoma

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

title
FDA drug approval summary: nelarabine (Arranon) for the treatment of T-cell lymphoblastic leukemia/lymphoma (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18586926
retrieved
30 July 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q34012525&oldid=1537531493"